TY - JOUR T1 - Incessant ovulation: a review of its importance in predicting cancer risk. A1 - Cramer,Daniel W, Y1 - 2023/10/06/ PY - 2023/06/14/received PY - 2023/08/16/accepted PY - 2023/10/23/medline PY - 2023/10/23/pubmed PY - 2023/10/23/entrez KW - breast cancer KW - estradiol KW - gynecologic cancer KW - ovulatory years KW - testosterone SP - 1240309 EP - 1240309 JF - Frontiers in oncology JO - Front Oncol VL - 13 N2 - Estrous cycles are recurring changes in therian mammals induced by estrogen, progesterone, and other hormones culminating in endometrial proliferation, ovulation, and implantation if fertilization occurred. In women, the estrous cycle is the menstrual cycle; but, unlike most mammals, the end of an infertile cycle is marked by endometrial sloughing and the start of another without an anestrous phase. Women stop cycling at menopause, while in most mammals, cycles continue until death. Epidemiologic studies identified menarche, menopause, births, lactation, and oral contraceptive (OC) use as key risk factors for ovarian, breast, and endometrial cancers. A composite variable was created to estimate the number of cycles not interrupted by events that stop ovulation. Captured by the phrase "incessant ovulation", repetitive cycles were first postulated to affect ovarian cancer risk and later extended to breast and endometrial cancers. These associations could be explained by cumulative effects of repetitive tissue changes within reproductive organs, immune consequences of repetitive ovulation through the glycoprotein mucin 1, and residual effects of past ovulations that enhance ovarian production of testosterone. The latter two pathways could affect the risk for cancers in other organs not considered "reproductive". SN - 2234-943X UR - https://www.unboundmedicine.com/medline/citation/37869082/full_citation DB - PRIME DP - Unbound Medicine ER -